Development of Parkinson’s Glove for Detection and Suppression of Hand Tremor

Overview

This study is aimed to study the feasibility and safety of parkinson's glove that combined 2 module of tremor detection and tremor suppression with electrical muscle stimulation for using as device for rest tremor suppression in parkinson's disease patients

Full Title of Study: “Development of Parkinson’s Glove for Detection and Suppression of Hand Tremor at Rest Among the Tremor-predominant Parkinson’s Disease Patients With Medically Intractable Tremor”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: Single (Participant)
  • Study Primary Completion Date: January 2016

Detailed Description

Study Population 1. Target: Thai Parkinson's disease (PD) patients with predominant rest tremor : 50 patients 2. Population sample: Patients who are getting their treatment at the Chulalongkorn Comprehensive Movement Disorder Clinic at King Chulalongkorn Memorial Hospital. Study methods as follows: – All PD subjects will be provided the information on this research study and informed consent will be sought for every subjects. – All PD subjects will be interviewed by a movememt disorders specialist or a trained interviewer for their demographic and clinical data. – All PD patients will be examined for the severity of Parkinson's disease by a movement disorders specialist according the Unified Parkinson's disease Rating Scale (UPDRS), Hoehn and Yahr score, and tremor rating scale during the 'on period' in order to determine the additional effect of parkinson's glove and sham glove for suppression of tremor – All PD patients will be randomly allocated into 2 groups (25 Parkinson's glove and 25 sham glove) with block randomization method. – All patients will get Parkinson's glove for home-based usage for 14 days, the appointment for follow -up will be done for 4 times, with once daily phone call from investigators in order to check for improvement symptoms and all adverse events such as pain will be recorded and determined it severity by the visual analog scale. Data collection – Demographic and clinical data: age, gender, clinical diagnosis, tremor rating scale, pain score by visual analog scale , Parkinson's disease's severity score for each subject according to establishing standard rating scale. – Tremor parameters form Parkinson's glove will be collected in SD card as 5 parameters: Peak magnitude, RMS, Angle, Frequency, Q. Number of stimulation times will be recorded. Data analysis The statistical analysis in this study is based from SPSS program version 17. Categorical data will be analyzed for frequency and percentage. Continuous data will be analyzed by mean and standard deviation (SD). Non-parametric study would be preferred if the small sample size or in case of distribution of data do not present as normal distribution (determined by Kolmogorov-Smirnov test). The repeated ANOVA will be used for determined the efficacy of parkinson's glove in the difference times in follow up periods.

Interventions

  • Device: Parkinson’s glove
    • Parkinson’s glove had module for detection tremor by gyroscope/acceleroscope and suppression rest hand tremor with electrical muscle stimulation
  • Device: sham glove

Arms, Groups and Cohorts

  • Experimental: Parkinson’s glove
    • Parkinson’s glove 14 days use with 4 times follow-up
  • Placebo Comparator: sham glove
    • sham glove (with light and sound)14 days use with 4 times follow-up

Clinical Trial Outcome Measures

Primary Measures

  • Number of participants who demonstrate the tremor suppression after use parkinson’s glove
    • Time Frame: up to 1 month follow up period
    • To determine the tremor suppression after use the parkinson’s glove by the tremor rating scale

Secondary Measures

  • Number of Participants who report pain or any adverse events from parkinson’s glove
    • Time Frame: 14 days periods of using parkinson’s glove and in subsequent 1 month follow up period
    • To determine the safety of parkinson’s glove
  • Determine the severity of pain related with parkinson’s glove
    • Time Frame: 14 days periods of using parkinson’s glove
    • To determine the severity of pain by visual analog scale

Participating in This Clinical Trial

Inclusion Criteria

  • • Adults ≥ 18 years old. – Patients with Parkinson's disease diagnosed according to the UKPDSBB criteria with predominantly feature of rest tremor that intractable to medically treatment. – Informed consent Exclusion Criteria:

  • Patients with a history of cardiac arrhythmia, renal failure, hepatic failure, and pregnancy as well as those who had history of seizure or had the risk for tended to become seizure such as those who had focal brain lesions, encephalitis, and stroke patients. – Patients with a history of hand surgery and implanted screws or wires in hand area that supposed to place a surface EMG or EMS, as well as those patients who were implanted for electrical devices such as cardiac pacemaker, pulse generator of deep brain stimulation,and intrathecal baclofen pump. – Patients who cannot avoid the medication that may potentiate or attenuate tremor such as antihistamines, benzodiazepine, illicit drugs, and thyroid hormone supplement.

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 80 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Chulalongkorn University
  • Provider of Information About this Clinical Study
    • Principal Investigator: Roongroj Bhidayasiri, Comprehensive Movement Disorders Center – Chulalongkorn University
  • Overall Official(s)
    • Roongroj Bhidayasiri, MD, FRCP, Study Director, Chulalongkorn University
  • Overall Contact(s)
    • Onanong Jitkritsadakul, MD, MSc, 0863570212, onanong.jit@gmail.com

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.